Effects of Milnacipran on Clinical Pain and Hyperalgesia of Patients with Fibromyalgia: Results of a 6-Week Randomized Controlled Trial

Journal of Pain

Volumn 16, Issue 8, 2015, Pages 750-759

  Staud, Roland ^a   Lucas, Yesenia E ^a   Price, Donald D ^b   Robinson, Michael E ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

clinical pain; clinical trial; Fibromyalgia; hyperalgesia; milnacipran; placebo

Indexed keywords

MILNACIPRAN; PLACEBO; CYCLOPROPANE DERIVATIVE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FATIGUE; FEMALE; FIBROMYALGIA; HEAT; HUMAN; HYPERALGESIA; MALE; MECHANICAL HYPERALGESIA; NOCICEPTION; PAIN; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; VISUAL ANALOG SCALE; ADVERSE EFFECTS; ANALYSIS OF VARIANCE; AREA UNDER THE CURVE; COMPLICATION; DRUG EFFECTS; MIDDLE AGED; PAIN THRESHOLD; QUESTIONNAIRE; STIMULATION; TREATMENT OUTCOME;

ADULT; ANALYSIS OF VARIANCE; AREA UNDER CURVE; CYCLOPROPANES; DOUBLE-BLIND METHOD; FEMALE; FIBROMYALGIA; HUMANS; HYPERALGESIA; MALE; MIDDLE AGED; PAIN THRESHOLD; PHYSICAL STIMULATION; SEROTONIN UPTAKE INHIBITORS; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

EID: 84938591665     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2015.04.010     Document Type: Article

References (53)

1. L. Arendt-Nielsen, and K.G. Henriksson Pathophysiological mechanisms in chronic musculoskeletal pain (fibromyalgia): the role of central and peripheral sensitization and pain disinhibition Best Pract Res Clin Rheumatol 21 2007 465 480
2. A. Barkhuizen Pharmacologic treatment of fibromyalgia Curr Pain Headache Rep 5 2001 351 358
3. R. Baron, G. Hans, and A.H. Dickenson Peripheral input and its importance for central sensitization Ann Neurol 74 2013 630 636
4. J.C. Branco, O. Zachrisson, S. Perrot, and Y. Mainguy A European multicenter randomized double-blind placebo-controlled monotherapy clinical trial of milnacipran in treatment of fibromyalgia J Rheumatol 37 2010 851 859
5. D.A. Braunholtz, S.J. Edwards, and R.J. Lilford Are randomized clinical trials good for us (in the short term)? Evidence for a "trial effect" J Clin Epidemiol 54 2001 217 224
6. D.J. Clauw Fibromyalgia: A clinical review JAMA 311 2014 1547 1555
7. D.J. Clauw, P. Mease, R.H. Palmer, R.M. Gendreau, and Y. Wang Milnacipran for the treatment of fibromyalgia in adults: A 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial Clin Ther 30 2008 1988 2004
8. J. Cohen Statistical Power Analysis for the Behavioral Sciences 2nd ed. 1988 Erlbaum Hillsdale, NJ
9. European Medicines Agency: European Medicines Agency Comment of Milnacipran. Available at: http://www.ema.europa.eu/docs/en-GB/document-library/Summary-of-opinion---Initial-authorisation/human/001034/WC500089875.pdf. 2014. Ref Type: Statute
10. D.L. Goldenberg Pharmacological treatment of fibromyalgia and other chronic musculoskeletal pain Best Pract Res Clin Rheumatol 21 2007 499 511
11. J.D. Greenspan, G.D. Slade, E. Bair, R. Dubner, R.B. Fillingim, R. Ohrbach, C. Knott, F. Mulkey, R. Rothwell, and W. Maixner Pain sensitivity risk factors for chronic TMD: Descriptive data and empirically identified domains from the OPPERA case-control study J Pain 12 2011 T61 T74
12. W. Hauser, F. Petzke, N. Uceyler, and C. Sommer Comparative efficacy and acceptability of amitriptyline, duloxetine and milnacipran in fibromyalgia syndrome: A systematic review with meta-analysis Rheumatology 50 2010 532 543
13. IASP Taxonomy. Available at: http://www.iasp-pain.org/Taxonomy?navItemNumber=576#Hyperalgesia. Accessed June 24, 2015
14. T. King, S. Rao, T. Vanderah, Q. Chen, A. Vardanyan, and F. Porreca Differential blockade of nerve injury-induced shift in weight bearing and thermal and tactile hypersensitivity by milnacipran J Pain 7 2006 513 520
15. M. Kwon, M. Altin, H. Duenas, and L. Alev The role of descending inhibitory pathways on chronic pain modulation and clinical implications Pain Pract 20 2013 10
16. K. Matsuzawa-Yanagida, M. Narita, M. Nakajima, N. Kuzumaki, K. Niikura, H. Nozaki, T. Takagi, E. Tamai, N. Hareyama, M. Terada, M. Yamazaki, and T. Suzuki Usefulness of antidepressants for improving the neuropathic pain-like state and pain-induced anxiety through actions at different brain sites Neuropsychopharm 33 2008 1952 1965
17. A. Matthey, C. Cedraschi, V. Piguet, M. Besson, J. Chabert, Y. Daali, D. Courvoisier, A. Montagne, P. Dayer, and J.A. Desmeules Dual reuptake inhibitor milnacipran and spinal pain pathways in fibromyalgia patients: A randomized, double-blind, placebo-controlled trial Pain Physician 16 2013 E553 E562
18. R. McCarney, J. Warner, S. Iliffe, R. van Haselen, M. Griffin, and P. Fisher The Hawthorne Effect: A randomised, controlled trial BMC Med Res Methodol 7 2007 30
19. P.J. Mease, D.J. Clauw, R.M. Gendreau, S.G. Rao, J. Kranzler, W. Chen, and R.H. Palmer the efficacy and safety of milnacipran for treatment of fibromyalgia. A randomized, double-blind, placebo-controlled trial J Rheumatol 36 2009 398 409
20. I. Melnikova Pain market Nat Rev Drug Discov 9 2010 589 590
21. S. O'Neill, C. Manniche, T. Graven-Nielsen, and L. Arendt-Nielsen Generalized deep-tissue hyperalgesia in patients with chronic low-back pain Eur J Pain 11 2007 415 420
22. F. Petzke, K.B. Jensen, E. Kosek, E. Choy, S. Carville, P. Fransson, S.C.R. Williams, H. Marcus, Y. Mainguy, M. Ingvar, and R.H. Gracely Using fMRI to evaluate the effects of milnacipran on central pain processing in patients with fibromyalgia Scand J Pain 4 2013 65 74
23. D.D. Price, F.M. Bush, S. Long, and S.W. Harkins A comparison of pain measurement characteristics of mechanical visual analogue and simple numerical rating scales Pain 56 1994 217 226
24. D.D. Price, and R. Dubner Mechanisms of first and second pain in the peripheral and central nervous systems J Invest Dermatol 69 1977 167 171
25. D.D. Price, J.W. Hu, R. Dubner, and R.H. Gracely Peripheral suppression of first pain and central summation of second pain evoked by noxious heat pulses Pain 3 1977 57 68
26. D.B. Reichling, and J.D. Levine Critical role of nociceptor plasticity in chronic pain Trends Neurosci 32 2009 611 618
27. R. Rolke, R. Baron, C. Maier, T.R. Tolle, R.D. Treede, A. Beyer, A. Binder, N. Birbaumer, F. Birklein, I.C. Botefur, S. Braune, H. Flor, V. Huge, R. Klug, G.B. Landwehrmeyer, W. Magerl, C. Maihofner, C. Rolko, C. Schaub, A. Scherens, T. Sprenger, M. Valet, and B. Wasserka Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): Standardized protocol and reference values Pain 123 2006 231 243
28. J. Serra, A. Collado, R. Sola, F. Antonelli, X. Torres, M. Salgueiro, C. Quiles, and H. Bostock Hyperexcitable C nociceptors in fibromyalgia Ann Neurol 75 2014 196 208
29. R. Staud Mechanisms of fibromyalgia pain CNS Spectr 14 2009 4 5
30. R. Staud The important role of CNS facilitation and inhibition for chronic pain Int J Clin Rheumtol 8 2013 639 646
31. R. Staud, C.E. Bovee, M.E. Robinson, and D.D. Price Cutaneous C-fiber abnormalities of fibromyalgia patients are specifically related to temporal summation Pain 139 2008 315 325
32. R. Staud, R.C. Cannon, A.P. Mauderli, M.E. Robinson, D.D. Price, and C.J. Vierck Temporal summation of pain from mechanical stimulation of muscle tissue in normal controls and subjects with fibromyalgia syndrome Pain 102 2003 87 95
33. R. Staud, D.D. Price, and R.B. Fillingim Advanced continuous-contact heat pulse design for efficient temporal summation of second pain (wind-up) J Pain 7 2006 575 582
34. R. Staud, M.E. Robinson, and D.D. Price Do past pain events systematically impact pain ratings of healthy subjects or fibromyalgia patients? J Pain 11 2010 142 148
35. R. Staud, M.E. Robinson, C.J. Vierck, R.L. Cannon, A.P. Mauderli, and D.D. Price Ratings of experimental pain and pain-related negative affect predict clinical pain in patients with fibromyalgia syndrome Pain 105 2003 215 222
36. R. Staud, M.E. Robinson, E.E. Weyl, and D.D. Price Pain variability in fibromyalgia is related to activity and rest: role of peripheral tissue impulse input J Pain 11 2010 1376 1383
37. R. Staud, E.E. Weyl, E. Bartley, D.D. Price, and M.E. Robinson Analgesic and anti-hyperalgesic effects of muscle injections with lidocaine or saline in patients with fibromyalgia syndrome Eur J Pain 18 2014 803 812
38. R. Staud, E.E. Weyl, D.D. Price, and M.E. Robinson Mechanical and heat hyperalgesia highly predict clinical pain intensity in patients with chronic musculoskeletal pain syndromes J Pain 13 2012 725 735
39. R. Staud, E.E. Weyl, J.L. Riley III, and R.B. Fillingim Slow temporal summation of pain for assessment of central pain sensitivity and clinical pain of fibromyalgia patients PLoS One 9 2014 e89086
40. R. Takeda, Y. Watanabe, T. Ikeda, H. Abe, K. Ebihara, H. Matsuo, H. Nonaka, H. Hashiguchi, T. Nishimori, and Y. Ishida Analgesic effect of milnacipran is associated with c-Fos expression in the anterior cingulate cortex in the rat neuropathic pain model Neurosci Res 64 2009 380 384
41. R.D. Treede, R.A. Meyer, S.N. Raja, and J.N. Campbell Peripheral and central mechanisms of cutaneous hyperalgesia Prog Neurobiol 38 1992 397 421
42. N. Uceyler, D. Zeller, A.K. Kahn, S. Kewenig, S. Kittel-Schneider, A. Schmid, J. Casanova-Molla, K. Reiners, and C. Sommer Small fibre pathology in patients with fibromyalgia syndrome Brain 136 2013 1857 1867
43. B. Verdu, I. Decosterd, T. Buclin, F. Stiefel, and A. Berney Antidepressants for the treatment of chronic pain Drugs 68 2008 2611 2632
44. G.N. Verne, M.E. Robinson, and D.D. Price Hypersensitivity to visceral and cutaneous pain in the irritable bowel syndrome Pain 93 2001 7 14
45. J.B. Wade, L.M. Dougherty, C.R. Archer, and D.D. Price Assessing the stages of pain processing: A multivariate analytical approach Pain 68 1996 157 167
46. F. Wolfe, H.A. Smythe, M.B. Yunus, R.M. Bennett, C. Bombardier, D.L. Goldenberg, P. Tugwell, S.M. Campbell, M. Abeles, P. Clark, A.G. Fam, S.J. Farber, J.J. Fiechtner, C.M. Franklin, R.A. Gatter, D. Hamaty, J. Lessard, A.S. Lichtbroun, A.T. Masi, G.A. McCain, W.J. Reynolds, T.J. Romano, I.J. Russell, and R.P. Sheon The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee Arthritis Rheumatol 33 1990 160 172
47. C.J. Woolf Evidence for a central component of post-injury pain hypersensitivity Nature 306 1983 686 688
48. C.J. Woolf An overview of the mechanisms of hyperalgesia Pulm Pharmacol 8 1995 161 167
49. C.J. Woolf Central sensitization: Implications for the diagnosis and treatment of pain Pain 152 2011 S2 S15
50. D. Yarnitsky, M. Granot, and Y. Granovsky Pain modulation profile and pain therapy: Between pro- and antinociception Pain 155 2014 663 665
51. D. Yarnitsky, M. Granot, H. Nahman-Averbuch, M. Khamaisi, and Y. Granovsky Conditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathy Pain 153 2012 1193 1198
52. D. Yarnitsky, D.A. Simone, R.M. Dotson, M.A. Cline, and J.L. Ochoa Single C nociceptor responses and psychophysical parameters of evoked pain: Effect of rate of rise of heat stimuli in humans J Physiol 450 1992 581 592
53. D.C. Yeomans, and H.K. Proudfit Nociceptive responses to high and low rates of noxious cutaneous heating are mediated by different nociceptors in the rat: electrophysiological evidence Pain 68 1996 141 150